Drug & intervention

romidepsin

RxCUI 877510

Clinical trials13
Recruiting0
Related conditions20
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

13 shown
Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast CancerNCT03432741 · 2018-03-27
TERMINATED
Early Administration of Romidepsin and 3BNC117 in Treatment-naïve HIV Patients Starting ARTNCT03041012 · 2017-01-20
COMPLETED
Romidepsin Plus 3BNC117 Phase 2a StudyNCT02850016 · 2017-01-06
COMPLETED
Study to Evaluate the Safety and Effect of HIVconsv Vaccines in Combination With Histone Deacetylase Inhibitor Romidepsin on the Viral Rebound Kinetic After Treatment Interruption in Early Treated HIV-1 Infected IndividualsNCT02616874 · 2016-02-01
COMPLETED
Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)NCT02393794 · 2015-07-17
ACTIVE_NOT_RECRUITING
Evaluating the Safety and Efficacy of Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral LoadNCT01933594 · 2014-05-05
COMPLETED
Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast CancerNCT01938833 · 2014-04-01
TERMINATED
Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV-1 ReservoirNCT02092116 · 2014-03-01
COMPLETED
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionNCT01638533 · 2012-08-03
COMPLETED
FR901228 in Treating Patients With Metastatic Breast CancerNCT00098397 · 2005-02-01
COMPLETED
Romidepsin in Treating Patients With Relapsed Small Cell Lung CancerNCT00086827 · 2004-05-01
COMPLETED
Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine TumorsNCT00084461 · 2004-03-01
TERMINATED
A Research Study for Patients With Prostate CancerNCT00106418 · 2003-05-07
COMPLETED

Conditions being studied

HIV2Male Breast Cancer2Recurrent Breast Cancer2Recurrent Breast Carcinoma2Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma2Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma2Stage IV Breast Cancer2Stage IV Breast Cancer AJCC v6 and v72Breast Adenocarcinoma1Breast Cancer1Gastrinoma1Glioma1Glucagonoma1Hematopoietic and Lymphoid Cell Neoplasm1HER2-negative Breast Cancer1HIV I Infection1HIV Infections1Human Immunodeficiency Virus (HIV)1Inflammatory Breast Cancer1Insulinoma1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.